The increasing prevalence of type II diabetes mellitus (T2DM) is a worldwide healthcare
concern. Over the years, our understanding of T2DM has grown considerably in uncovering …

Diabetes mellitus (DM), one of the oldest diseases known to mankind has always been
difficult to treat even with the availability of a variety of medications. In such a scenario, the …

Importance to the field: There is a large unmet need for new therapies to treat type 2
diabetes (T2DM) which reduce fasting and postprandial glucose without increasing insulin …

Objective: To review the pharmacologic characteristics, safety, and efficacy of bromocriptine
mesylate for glycemic control in patients with type 2 diabetes mellitus. Data Sources: A …

An extended series of studies indicate that endogenous phase shifts in circadian neuronal
input signaling to the biological clock system centered within the hypothalamic …

Type 2 diabetes mellitus (T2DM) remains uncontrolled in a large number of patients despite
advances in medical treatment. Bromocriptine mesylate is a quick release preparation of …

Cardiovascular risk reduction is a key priority in patients with diabetes. The relationship
between glycemic control and macrovascular outcomes, such as the benefit of intensive …

Type 2 diabetes mellitus (T2DM) continues to rise in prevalence in the United States and
worldwide. Despite advances in medical treatments for T2DM, many patients remain …

Bromocriptine: Its place in type 2 diabetes Tx Page 1 jfponline.com Vol 60, no 11 | noVemBeR
2011 | The jouRnal of family pRacTice E1 Karen R. Sando, PharmD, CDE; James Taylor …

Bromocriptine-QR (quick release) is a novel treatment for type 2 diabetes. The objective of
this study is to assess the efficacy and safety of bromocriptine-QR in adults with type 2 …